about
FeverAspirin-exacerbated asthma.Role of G protein-coupled receptors in inflammation.Aspirin and other anti-inflammatory drugs.Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskAmeliorative effect of ocimum sanctum on meloxicam induced toxicity in wistar rats.Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use.Pregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopiaA comparison of the analgesic effects of butorphanol with those of meloxicam after elective ovariohysterectomy in dogs.Molecular aspects of thrombosis and antithrombotic drugs.20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.The classical vs nonclassical NSAIDs: can the reduction in pain overcome the thrombotic risk?Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell LineThe future of osteoarthritis therapeutics: targeted pharmacological therapyUse of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung CancerLong-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in ratsTransfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor.Involvement of extracellular Ca2+ influx and epidermal growth factor receptor tyrosine kinase transactivation in endothelin-1-induced arachidonic acid release.Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis.Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.The effect of non-steroidal anti-inflammatory drugs on severity of acute pancreatitis and pancreatic necrosis.Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats.
P2860
Q24603393-56BFBF38-7DE4-42CA-B1AE-F06852FC7E43Q33846722-56D2D82F-2EB6-4DF6-ADE7-E27762AC0784Q33858841-4F2CC7FD-CFB5-46C5-A727-2EA911E6ECDAQ34036177-24AB1294-5FA9-471B-A499-BEAA1770A599Q34045455-5ED66075-8BAD-4174-9B90-2D099C08D84BQ34651032-C25446E8-3BEE-42F9-92A6-50BA44ACDF59Q34794017-E697AA9D-1BC8-45E4-B1CB-33D7E746D0DFQ35245147-2296A452-8352-4B0C-8F24-59895F44E4EEQ35803721-89BCF6F5-5429-4AF3-95B9-9E54E8E4BF4DQ35811049-CC821231-639F-4EB6-8E36-E8AB077C3B20Q36108547-6FD81B42-15DD-419D-916D-F6CFCD571147Q36209119-0172C285-9DEE-461A-AA42-FBD9A84485C8Q36531189-D4778EF2-B3FA-4AEE-BE5A-32B120B8F973Q36953015-B3AE2CE2-040C-4C4C-ACC7-DC1D0C25B1C8Q37057444-BDFE5650-939D-4450-B37B-D507BCB5DBD5Q37213622-2701EC97-E2FD-4343-BE21-E8664679F3D5Q37306176-A537227C-65E4-4193-A5A6-8FD82FF2AB77Q37475804-DF35F733-2F53-4285-9918-15A91C1B24FBQ40918222-956A55C5-AF54-4449-94F6-86B1D24CF3E3Q40973670-A17583D0-DDF6-47F5-AF86-9FEB5320E384Q41912058-32E47EC3-2B58-4FEB-A752-3756174824CAQ44320255-DDB966A2-9E0C-4341-A3F2-C2FAC3361BE5Q46437862-5132D6A4-6D4E-445A-A43E-A90B35CC58E4Q47357187-00376F9B-F6B4-490E-BC3E-E439723DF7ABQ55378545-0D04BFD0-BD20-4C58-B1B1-38AE5DEE2999
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mechanism of action of aspirin-like drugs.
@en
type
label
Mechanism of action of aspirin-like drugs.
@en
prefLabel
Mechanism of action of aspirin-like drugs.
@en
P1476
Mechanism of action of aspirin-like drugs.
@en
P2093
P356
10.1016/S0049-0172(97)80046-7
P433
P577
1997-06-01T00:00:00Z